Zhang, L., Wang, Y., Schuemie, M. J., Blei, D. M., & Hripcsak, G. (2022). Adjusting for indirectly measured confounding using large-scale propensity score. Journal of Biomedical Informatics, 134, 104204. https://doi.org/10.1016/j.jbi.2022.104204

Ycaza, M., Keating, C., DiMango, E., Lopez, J., Saroya, T., & McNeill, T. (2022). 52 Participation in interventional drug trials of minority populations at an urban adult cystic fibrosis center. Journal of Cystic Fibrosis, 21, S32. https://doi.org/10.1016/s1569-1993(22)00743-3

Knox, J., & Curran, G. M. (2022). Merging lanes for science. Frontiers in Health Services, 2. https://doi.org/10.3389/frhs.2022.968175

Moran, A. E., Farrell, M., Cazabon, D., Sahoo, S. K., Mugrditchian, D., Pidugu, A., Chivardi, C., Walbaum, M., Alemayehu, S., Isaranuwatchai, W., Ankurawaranon, C., Choudhury, S. R., Pickersgill, S. J., Watkins, D. A., Husain, M. J., Rao, K. D., Matsushita, K., Marklund, M., Hutchinson, B., … Garg, R. (2022). Building the health-economic case for scaling up the WHO-HEARTS hypertension control package in low- and middle-income countries. Revista Panamericana de Salud Pública, 46, 1. https://doi.org/10.26633/rpsp.2022.140

Nguyen, D., Kandzari, D., El-Zein, R., Gosch, K., Kirtane, A., Yeh, R., Karmpaliotis, D., Spertus, J., Arnold, S., Grantham, J. A., & Salisbury, A. (2022). TCT-98 The Impact of Frailty on 1-Year Mortality After Percutaneous Coronary Intervention in Patients With Complex Coronary Artery Disease and Prohibitive Risk for Bypass Surgery. Journal of the American College of Cardiology, 80(12), B39. https://doi.org/10.1016/j.jacc.2022.08.118

Aschenbrenner, A. J., Hassenstab, J., Wang, G., Li, Y., Xiong, C., McDade, E., Clifford, D. B., Salloway, S., Farlow, M., Yaari, R., Cheng, E. Y. J., Holdridge, K. C., Mummery, C. J., Masters, C. L., Hsiung, G.-Y., Surti, G., Day, G. S., Weintraub, S., Honig, L. S., … Bateman, R. J. (2022). Avoid or Embrace? Practice Effects in Alzheimer’s Disease Prevention Trials. Frontiers in Aging Neuroscience, 14. https://doi.org/10.3389/fnagi.2022.883131

Yu, J. B. (2022). Fostering Transdisciplinary Collaborations in Cancer Health Economics Research. JNCI Monographs, 2022(59), 85–88. https://doi.org/10.1093/jncimonographs/lgac001

Bryan, A., Mobley, C., Moran, A., Derington, C., Zhang, Y., Rodgers, A., Shea, S., & Bellows, B. (2022). EE310 Cost-Effectiveness of Initiating Antihypertensive Therapy with Single-Pill Combinations Versus Monotherapy in US Adults. Value in Health, 25(7), S394. https://doi.org/10.1016/j.jval.2022.04.555

Maisel-Campbell, A., Schlessinger, D. I., Yanes, A. F., Veledar, E., Reynolds, K. A., Ibrahim, S. A., Kang, B. Y., Anvery, N., Poon, E., & Alam, M. (2022). Voting behavior during FDA Medical Device Advisory Committee panel meetings. PLOS ONE, 17(6), e0267134. https://doi.org/10.1371/journal.pone.0267134

Sahoo, S. K., Pathni, A. K., Krishna, A., Sharma, B., Cazabon, D., Moran, A. E., & Hering, D. (2022). ESTIMATES ON MEDICATION COST OF DRUG DOSE SPECIFIC TREATMENT PROTOCOL FOR HYPERTENSION MANAGEMENT IN PUBLIC AND PRIVATE HEALTHCARE SECTORS IN INDIA. Journal of Hypertension, 40(Suppl 1), e232. https://doi.org/10.1097/01.hjh.0000837844.63102.4a

Kohli-Lynch, C. N., Lewsey, J., Boyd, K. A., French, D. D., Jordan, N., Moran, A. E., Sattar, N., Preiss, D., & Briggs, A. H. (2022). Beyond 10-Year Risk: A Cost-Effectiveness Analysis of Statins for the Primary Prevention of Cardiovascular Disease. Circulation, 145(17), 1312–1323. https://doi.org/10.1161/circulationaha.121.057631

Kostick-Quenet, K. M., Blumenthal-Barby, J., Mehra, M., Lang, B., Dorfman, N., Bhimaraj, A., Civitello, A., Jorde, U., Trachtenberg, B., Uriel, N., Kaplan, H., Gilmore-Szott, E., Volk, R., & Estep, J. (2022). Integrating Personalized Risk Scores in Decision Making About Left Ventricular Assist Device (LVAD) Therapy: Clinician and Patient Perspectives. The Journal of Heart and Lung Transplantation, 41(4), S230. https://doi.org/10.1016/j.healun.2022.01.1714

Yap, C., Solovyeva, O., Yin, Z., Martin, J., Manickavasagar, T., Weir, C., Lee, S., Dimairo, M., Liu, R., Kightley, A., & de Bono, J. S. (2022). 53P Assessing the reporting quality of early phase dose-finding trials. Annals of Oncology, 33, S24. https://doi.org/10.1016/j.annonc.2022.01.018

Carter, S. A., Lightstone, L., Cattran, D., Tong, A., Bagga, A., Barbour, S. J., Barratt, J., Boletis, J., Caster, D. J., Coppo, R., Fervenza, F. C., Floege, J., Hladunewich, M. A., Hogan, J. J., Kitching, A. R., Lafayette, R. A., Malvar, A., Radhakrishnan, J., Rovin, B. H., … Craig, J. C. (2022). A Core Outcome Set for Trials in Glomerular Disease. Clinical Journal of the American Society of Nephrology, 17(1), 53–64. https://doi.org/10.2215/cjn.07840621

Butala, N. M., Raja, A., Xu, J., Strom, J. B., Schermerhorn, M., Beckman, J. A., Shishehbor, M. H., Shen, C., Yeh, R. W., & Secemsky, E. A. (2021). Association of Frailty With Treatment Selection and Long‐Term Outcomes Among Patients With Chronic Limb‐Threatening Ischemia. Journal of the American Heart Association, 10(24). https://doi.org/10.1161/jaha.121.023138

Bajorek, L. P., Kiekhofer, R., Hall, M., Taylor, J., Lucente, D. E., Brushaber, D., Appleby, B., Coppolla, G., Bordelon, Y. M., Botha, H., Dickerson, B. C., Dickson, D. W., Domoto‐Reilly, K., Fagan, A. M., Fields, J. A., Fong, J. C., Foroud, T. M., Forsberg, L. K., … Galasko, D. R. (2021). Demographic and psychosocial factors associated with the decision to learn mutation status in familial frontotemporal dementia and the impact of disclosure on mood. Alzheimer’s & Dementia, 17(S7). Portico. https://doi.org/10.1002/alz.050692